Alexis Benjamin
Physician Assistant · Charlotte, NCNPI 1649592189
Payments from drug & device makers
Across 362 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Gilead$785
- Novo Nordisk$579
- Lilly USA, LLC$459
- AstraZeneca$428
- Orexo US, Inc.$250
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,880100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $1,333 |
| Gilead | 32 | $785 |
| Novo Nordisk | 60 | $579 |
| Lilly USA, LLC | 26 | $459 |
| AstraZeneca | 23 | $428 |
| Orexo US, Inc. | 13 | $250 |
| Boehringer Ingelheim | 12 | $214 |
| Otsuka America Pharmaceutical, Inc. | 9 | $168 |
| Nestle Healthcare Nutrition Inc. | 7 | $167 |
| Abbott | 6 | $133 |
| Braeburn Inc. | 7 | $132 |
| GSK | 7 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $122 |
| Mylan Specialty L.p. | 7 | $114 |
| Daiichi Sankyo Inc. | 6 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $109 |
| Viatris Specialty LLC | 5 | $98 |
| Amgen | 5 | $86 |
| Pfizer | 3 | $64 |
| Johnson & Johnson | 4 | $62 |
| Indivior Inc. | 1 | $40 |
| Merck | 2 | $38 |
| Lundbeck LLC | 2 | $34 |
| Redhill Biopharma Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $27 |
| Amarin Pharma, Inc. | 2 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Corium, LLC | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$5,880 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 131 | $155,068 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 163 | $107,189 |
| EliquisApixaban | 50 | $55,074 |
| LinzessLinaclotide | 74 | $54,534 |
| Tresiba Flextouch U-100Insulin Degludec | 90 | $54,327 |
| FarxigaDapagliflozin Propanediol | 53 | $52,869 |
| JanuviaSitagliptin Phosphate | 42 | $50,324 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 291 | $48,593 |
| Xtampza ErOxycodone Myristate | 33 | $37,948 |
| JardianceEmpagliflozin | 28 | $33,104 |
| EntrestoSacubitril/Valsartan | 28 | $28,315 |
| SublocadeBuprenorphine | 13 | $26,791 |
| ZenpepLipase/Protease/Amylase | 12 | $23,303 |
| VraylarCariprazine Hcl | 13 | $19,859 |
| MounjaroTirzepatide | 14 | $16,537 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $428 | $172,545268 claims |
| Novo NordiskOzempic | $579 | $155,068131 claims |
| AbbVieLinzess, Vraylar | $1,333 | $74,39387 claims |
| PfizerEliquis | $64 | $55,07450 claims |
| MerckJanuvia | $38 | $50,32442 claims |
| Boehringer IngelheimJardiance | $214 | $33,10428 claims |
| Indivior Inc.Sublocade | $40 | $26,79113 claims |
| Lilly USA, LLCMounjaro | $459 | $16,53714 claims |
| Orexo US, Inc.Zubsolv | $250 | $7,82413 claims |
| GSKTrelegy Ellipta | $125 | $7,73212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Charlotte
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Kristin CabedaCharlotte$135K
- Meghan EmigCharlotte$124K
- Juleidy TurnipseedCharlotte$84K
- Erin SiceloffCharlotte$50K
- Ronald RodriguezCharlotte$31K
- Lamiaa TolbaCharlotte$29K
- Sanaya GandhiCharlotte$29K
- Jacqueline LeyrerCharlotte$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.